Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2

Abstract

(2016). Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2. Biochemical and Biophysical Research Communications, 476(2) This manuscript is distributed under a Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the author and source are cited. General rightsCopyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. In conclusion, the intrinsic fluorescent properties of STO-609 provide a great opportunity to utilise this drug to label the ATP-binding pocket and probe the impact of mutations and other regulatory modifications and interactions on the pocket. It is however clear that the number of phosphorylation sites on CaMKK2 will pose a challenge in studying the impact of phosphorylation on the pocket unless the field can develop approaches to control the spectrum of modifications that occur during recombinant protein expression in E. coli.

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma

“…GHRL was one of the DEIRGs identified in our study, which acts as a powerful appetite stimulant and plays a key role in energy homeostasis. GHRL can regulate whole-body metabolism via the ghrelin-signaling pathway in the hypothalamus and alter the metabolic activity of cancer and immune cells ( 44 ). A systematic analysis of immune-related genes between high- and low-MPRS subtypes to clarify the role of metabolism in cancer immunotherapy would be meaningful.…”

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

“…Because CaMKK2 appears to have pro-tumor functions in human GBM, and deletion of CaMKK2 extends survival in preclinical models, we expect that a brain penetrant CaMKK2 inhibitor may be efficacious as a monotherapy. Unfortunately, commercially available CaMKK2 inhibitors are neither very selective 42 nor brain penetrant 43 . Therapeutic targets which selectively re-polarize the stromal elements of the TME to anti-tumor phenotypes and enable ICB therapy have been limited, particularly in immunologically cold tumors such as GBM.…”

Data for the co-expression and purification of human recombinant CaMKK2 in complex with calmodulin in Escherichia coli

“…Here, we describe the expression in Escherichia coli and the purification protocol for the following constructs: full-length CaMKK2 in complex with CaM, CaMKK2 ‘apo’, CaMKK2 (165-501) in complex with CaM, and the CaMKK2 F267G mutant. The protocols described have been optimized for maximum yield and purity with minimal purification steps required and the proteins subsequently used to develop a fluorescence-based assay for drug binding to the kinase, “Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2” [1] .…”